Jimenez et al. injected AAV1-FGF21 into aged mouse muscle, promoting long-term increased circulating levels of FGF21 in the blood, which reversed age-related insulin resistance, weight gain, and cognitive decline, extending the healthy lifespan of mice (Jimenez et al., 2024). The gene discussed is FGF21; the disease is age.